NG2-Glia Cause Diabetic Blood-Brain Barrier Disruption by Secreting MMP-9
Diabetes & Metabolism Journal · 2026
DOI: 10.4093/dmj.2023.0342 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, 2026. Verfasst von Xiaolong Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center, Second Affiliated Hospital, Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 9, Blood-Brain Barrier, Diabetes Mellitus, Type 2, Neuroglia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Chongqing Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Disorders of the blood-brain barrier (BBB) arising from diabetes mellitus are closely related to diabetic encephalopathy. Previous research has suggested that neuron-glia antigen 2 (NG2)-glia plays a key role in maintaining the integrity of the BBB. However, the mechanism by which NG2-glia regulates the diabetic BBB remains unclear.
Methods
Type 2 diabetes mellitus (T2DM) db/db mice and db/m mice were used. Evans-Blue BBB permeability tests and transmission electron microscopy techniques were applied. Tight junction proteins were assessed by immunofluorescence and transmission electron microscopy. NG2-glia number and signaling pathways were evaluated by immunofluorescence. Detection of matrix metalloproteinase-9 (MMP-9) in serum was performed using enzyme-linked immunosorbent assay (ELISA).
Results
In T2DM db/db mice, BBB permeability in the hippocampus significantly increased from 16 weeks of age, and the structure of tight junction proteins changed. The number of NG2-glia in the hippocampus of db/db mice increased around microvessels from 12 weeks of age. Concurrently, the expression of MMP-9 increased in the hippocampus with no change in serum. Sixteen- week-old db/db mice showed activation of the Wnt/β-catenin signaling in hippocampal NG2-glia. Treatment with XAV-939 improved structural and functional changes in the hippocampal BBB and reduced MMP-9 secretion by hippocampal NG2-glia in db/db mice. It was also found that the upregulation of β-catenin protein in NG2-glia in the hippocampus of 16-week-old db/db mice was significantly alleviated by treatment with XAV-939.
Conclusion
The results indicate that NG2-glia can lead to structural and functional disruption of the diabetic BBB by activating Wnt/β-catenin signaling, upregulating MMP-9, and degrading tight junction proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Center, Second Affiliated Hospital, Army Medical University, Chongqing, China.
- Teaching and Research Office, Southwest Hospital Jiangbei Area (The 958th Hospital of Chinese People's Liberation Army), Chongqing, China.
Förderung
- National Natural Science Foundation of China
- Chongqing Natural Science Foundation of China
Zitieren
APA
Li, X., Cai, Y., Zhong, Z., Li, M., Huang, D., Qiao, Z., Zhou, H., Zhang, Z., & Zhou, J. (2026). NG2-Glia Cause Diabetic Blood-Brain Barrier Disruption by Secreting MMP-9. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2023.0342
Vancouver
Li X, Cai Y, Zhong Z, Li M, Huang D, Qiao Z, et al. NG2-Glia Cause Diabetic Blood-Brain Barrier Disruption by Secreting MMP-9. Diabetes & Metabolism Journal. 2026. doi:10.4093/dmj.2023.0342
BibTeX
@article{Li2026,
author = {Li, Xiaolong and Cai, Yan and Zhong, Zhu and Li, Maolin and Huang, Dong and Qiao, Zhifei and Zhou, Hongli and Zhang, Zuo and Zhou, Jiyin},
title = {NG2-Glia Cause Diabetic Blood-Brain Barrier Disruption by Secreting MMP-9},
journal = {Diabetes & Metabolism Journal},
year = {2026},
doi = {10.4093/dmj.2023.0342}
}
EUVIMED